|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/48 | |
| A61K 31/437 | |||
| A61K 31/5377 | |||
| A61P 7/04 |
| (11) | Number of the document | 2950813 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14704915.9 |
| Date of filing the European patent application | 2014-01-23 | |
| (97) | Date of publication of the European application | 2015-12-09 |
| (45) | Date of publication and mention of the grant of the patent | 2019-09-04 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2014/058494 |
| Date | 2014-01-23 |
| (87) | Number | WO 2014/118677 |
| Date | 2014-08-07 |
| (30) | Number | Date | Country code |
| 201361759332 P | 2013-01-31 | US |
| (72) |
CAMIRE, Rodney, US
FRUEBIS, Joachim, US
PITTMAN, Debra D., US
|
| (73) |
Pfizer Inc.,
235 East 42nd Street, New York, NY 10017,
US
The Children`s Hospital of Philadelphia, 3401 Civic Center Boulevard, Philadelphia, PA 19104, US |
| (54) | COMPOSITIONS AND METHODS FOR COUNTERACTING FACTOR XA INHIBITION |
| COMPOSITIONS AND METHODS FOR COUNTERACTING FACTOR XA INHIBITION |